Through two days of talks, poster sessions, flash presentations and networking, the inaugural UK Proteostasis Conference will showcase diverse cutting-edge proteostasis research and address fundamental questions in the field, including how to expedite applications in pharmaceuticals, biotechnology, and agritech.
This conference will also launch the Proteostasis UK Network, which will unite the proteostasis community in the UK across the fields of protein folding, quality control, aggregation, degradation and beyond, to tackle challenges in fundamental biology and novel therapeutics through collaborations and sharing of resources, expertise and trainees.
Conference Speakers
We are delighted to be scheduling talks from academic and commercial research leaders in the proteostasis field, in addition to inviting flash talks to highlight a broad range of research from academic teams, and a panel discussion with pharmceutical leads.
Keynote Talk: Professor Rick Morimoto; Director of the Rice Institute for Biomedical Research at Northwestern University and Royal Society Wolfson Visiting Fellow at the University of Cambridge - The Proteostasis Network as a Biological Clock for Health, Aging and Disease
Professor Pedro Carvalho; Sir William Dunn School of Pathology, University of Oxford - Quality control of membrane proteins
Professor Sheena Radford; Faculty of Biological Sciences, University of Leeds - The challenges of predicting amyloidogenicity
Professor Steven Spoel; Institute of Molecular Plant Sciences, University of Edinburgh - Diverse ubiquitin chain topologies orchestrate plant immune signalling
Professor Paul Workman; Signal Transduction & Molecular Pharmacology team, Institute of Cancer Research - Discovery and development of NXP800: a clinical stage GCN2/ISR activator that inhibits HSF1 transcription for the treatment of ARID1A mutant ovarian cancer
Dr Rahul Samant; Group Leader, Babraham Institute - Deconvoluting cellular proteostasis strategies across proliferative states
Dr Benedict Cross; Chief Technology Officer, PhoreMost - Induced control of protein degradation
Dr Bernadette M Carroll; Senior Research Fellow, University of Bristol - Exploring lysosomal dysfunction in cellular senescence
Professor Rachel Simmonds; Head of the Department of Microbial Sciences and Professor of Immunopathogensis, University of Surrey - Dysregulated proteostasis as a virulence mechanism of pathogenic bacteria, the case of the Mycobacterium ulcerans exotoxin mycolactone
Dr Ivana Bjedov; Principal Research Fellow, Molecular Biology of Cancer Research Group, UCL Cancer Institute - Increased fidelity of protein synthesis extends lifespan
Professor Tuomas Knowles; Department of 91AV, University of Cambridge - Protein phase transitions
Dr Rebecca Taylor; School of Biological Sciences, University of East Anglia - How neuronal signalling connects perception with proteostasis and ageing
This conference will also launch the Proteostasis UK Network, which will unite the proteostasis community in the UK across the fields of protein folding, quality control, aggregation, degradation and beyond, to tackle challenges in fundamental biology and novel therapeutics through collaborations and sharing of resources, expertise and trainees.
Conference Speakers
We are delighted to be scheduling talks from academic and commercial research leaders in the proteostasis field, in addition to inviting flash talks to highlight a broad range of research from academic teams, and a panel discussion with pharmceutical leads.
Keynote Talk: Professor Rick Morimoto; Director of the Rice Institute for Biomedical Research at Northwestern University and Royal Society Wolfson Visiting Fellow at the University of Cambridge - The Proteostasis Network as a Biological Clock for Health, Aging and Disease
Professor Pedro Carvalho; Sir William Dunn School of Pathology, University of Oxford - Quality control of membrane proteins
Professor Sheena Radford; Faculty of Biological Sciences, University of Leeds - The challenges of predicting amyloidogenicity
Professor Steven Spoel; Institute of Molecular Plant Sciences, University of Edinburgh - Diverse ubiquitin chain topologies orchestrate plant immune signalling
Professor Paul Workman; Signal Transduction & Molecular Pharmacology team, Institute of Cancer Research - Discovery and development of NXP800: a clinical stage GCN2/ISR activator that inhibits HSF1 transcription for the treatment of ARID1A mutant ovarian cancer
Dr Rahul Samant; Group Leader, Babraham Institute - Deconvoluting cellular proteostasis strategies across proliferative states
Dr Benedict Cross; Chief Technology Officer, PhoreMost - Induced control of protein degradation
Dr Bernadette M Carroll; Senior Research Fellow, University of Bristol - Exploring lysosomal dysfunction in cellular senescence
Professor Rachel Simmonds; Head of the Department of Microbial Sciences and Professor of Immunopathogensis, University of Surrey - Dysregulated proteostasis as a virulence mechanism of pathogenic bacteria, the case of the Mycobacterium ulcerans exotoxin mycolactone
Dr Ivana Bjedov; Principal Research Fellow, Molecular Biology of Cancer Research Group, UCL Cancer Institute - Increased fidelity of protein synthesis extends lifespan
Professor Tuomas Knowles; Department of 91AV, University of Cambridge - Protein phase transitions
Dr Rebecca Taylor; School of Biological Sciences, University of East Anglia - How neuronal signalling connects perception with proteostasis and ageing
